Ipilimumab vs Valsartan
Ipilimumab vs Valsartan: Overview
This comparison examines the pharmacological differences between Ipilimumab and Valsartan.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Valsartan: Angiotensin II type 1 receptor blocker.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Valsartan β 6 hours.
Chemical Properties
Molecular Formula: Valsartan β C24H29N5O3.
Molecular Weight: Valsartan β 435.5190 g/mol.
Type: Ipilimumab β Antibody; Valsartan β Small molecule.